The present study shows that inhibition of SIRT2 (shRNA-mediated knockdown and pharmacological by thiomyristoyl) resulted in sensitization of melanoma cells to the widely used anticancer drug cisplatin, most likely by targeting EGFR stability and downstream signaling. The gene discussed is EGFR; the disease is melanoma.